by Ingrid Niesman | Mar 3, 2017 | conditions
Table of Contents 1. Introduction: Morgellons Disease (MD) and its symptoms 2. The Rise of Tick-Borne Diseases, including Lyme Disease (LD) 3. Delusion or Reality? Two Contrasting Views on the Origins and Causation of MD 4. Evidence from Ultrastructural Pathology on a...
by Ingrid Niesman | Mar 2, 2017 | conditions
Table of Contents 1. Introduction 2. Fences keep neighborhoods friendly 3. How these pathways collide: AMPK is the hammer and GIV is the nail 4. Why stability matters 5. The anti-cancer mechanism of Metformin 6. The dark side: GIV mutations and tumor development 7....
by Ingrid Niesman | Mar 2, 2017 | conditions
Table of Contents 1. Introduction 2. Protein Sciences’ Zika Vaccine Candidate 3. BEVS Technology 4. Preclinical Studies Results 5. Toxicology Studies 6. Funding and Consortium Partners 7. Current Influenza Vaccine Production 8. Clinical Trial of National...
by Ingrid Niesman | Mar 2, 2017 | outbreaks
Table of Contents 1. Introduction: Overview of the Zika virus and its impact 2. WHO’s declaration on Zika infections 3. Spread and impact of Zika virus worldwide 4. NIAID’s role in developing vaccine candidates 5. Trials on rhesus monkeys and results 6. Human trials...
by Ingrid Niesman | Mar 2, 2017 | conditions
Table of Contents 1. Introduction: Alzheimer’s disease (AD) and its impact 2. Neuronal trafficking and its role in AD development 3. Dysfunctional neuronal trafficking 4. Key protein expression changes and mutations associated with AD 5. The role of ApoE and clathrin...
